Web Version  |  Digital Edition  |  Share

 

Dermatology Times

New Procedures

Advances in Therapy

New Products and Drugs

Interviews with Leaders in Pracice

Dermatology Times is a newsmagazine devoted to reporting timely information on the latest trends in the dermatology market. As such, it covers new procedures; advances in therapy, new products and drugs, the latest information presented at meetings, interviews with leaders in practice, academics and research.

In our upcoming issues:

Ongoing economic challenges and the increasing push to implement EHRs are causing many older dermatologists to retire. How will their absence impact the specialty?

Meloanoma in children -- Because melanoma in pediatric patients occurs very rarely, dermatologists should prioritize only those types of melanocytic nevi that can pose problems. Learn more about which nevi these might be.

Laser dilemma -- Read one case study involving infection with an emerging atypical pathogen after laser resurfacing.

Cosmeceutical questions -- Tips and tricks for dermatologists looking to provide patients with advice when “datapenia” challenges solid recommendations.

Subscribe Now!

eNewsletter

Digital Edition

Magazine

 

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.